| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/17/1994 | US5312430 For restoring patency to a collapsed portion of the urethra |
| 05/17/1994 | CA1329639C Magnetic resonance imaging |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994010567A1 Compaction assay for assessment of respiratory disease therapy |
| 05/11/1994 | WO1994010182A1 High relaxivity, paramagnetic, metal complexes for magnetic resonance imaging |
| 05/11/1994 | WO1994010172A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | WO1994010083A1 Method of recovering iodine from iodated organic compounds |
| 05/11/1994 | WO1994009829A1 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 05/11/1994 | WO1994009703A1 Surfactant-stabilized microbubble mixtures, process for preparing and methods of using the same |
| 05/11/1994 | EP0596011A1 Trifunctional compounds having specificity for multi-drug resistant cells |
| 05/11/1994 | EP0595924A1 Platelet activating factor antagonists |
| 05/11/1994 | CA2148372A1 Surfactant-stabilized microbubble mixtures, process for preparing and methods of using the same |
| 05/11/1994 | CA2147509A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | CA2147373A1 Method of recovering iodine from iodated organic compounds |
| 05/10/1994 | US5310893 Oligonucleotide probe |
| 05/10/1994 | US5310540 Foaming protein, shearing |
| 05/10/1994 | US5310539 Paramagnetic rare earth metals, magnetic resonance imaging |
| 05/10/1994 | US5310538 Contrast agents |
| 05/10/1994 | US5310537 Contrast agents |
| 05/05/1994 | DE4236724A1 Verfahren zur Rückgewinnung von Jod aus jodierten organischen Verbindungen Process for the recovery of iodine from iodinated organic compounds |
| 05/04/1994 | EP0594660A1 Bioassay method |
| 05/04/1994 | EP0594640A1 Liposoluble compounds for magnetic resonance imaging |
| 05/04/1994 | EP0434832B1 D8- and D9-PROSTAGLANDINE DERIVATES, THEIR PROCESS OF PRODUCTION AND THEIR PHARMACEUTICAL USE |
| 05/03/1994 | US5308701 Encapsulation biological material |
| 05/03/1994 | US5308608 Photosensitizing Diels-Alder porphyrin derivatives |
| 05/03/1994 | US5308607 Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast |
| 05/03/1994 | US5308604 Conjugates for tumor localization and/or tumor therapy |
| 05/03/1994 | US5307813 In vivo imaging microscopic interval regions of a patient's body |
| 04/28/1994 | WO1994009153A1 Method of detecting cell response to cell-damaging energy |
| 04/28/1994 | WO1994009056A1 Chelating polymers |
| 04/28/1994 | WO1994008631A1 The use of carotenoporphyrins as tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues |
| 04/28/1994 | WO1994008630A1 Novel compositions for magnetic resonance imaging |
| 04/28/1994 | WO1994008629A1 Mr imaging compositions, based on poly(alkyleneoxide) |
| 04/28/1994 | WO1994008627A1 Preparation of further diagnostic agents |
| 04/28/1994 | WO1994008626A1 Process and device for producing liquid, dispersed systems |
| 04/28/1994 | WO1994008624A2 Therapeutic and diagnostic imaging compositions and methods |
| 04/28/1994 | WO1994008509A1 Polymers as contrast media for magnetic resonance imaging |
| 04/28/1994 | CA2147151A1 Therapeutic and diagnostic imaging compositions and methods |
| 04/28/1994 | CA2146992A1 Mr imaging compositions, based on poly(alkyleneoxide) |
| 04/28/1994 | CA2146990A1 Chelating polymers |
| 04/28/1994 | CA2146986A1 Polymers as contrast media for magnetic resonance imaging |
| 04/28/1994 | CA2146963A1 Process and device for producing liquid, dispersed systems |
| 04/28/1994 | CA2126436A1 The use of carotenoporphyrins a tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues |
| 04/27/1994 | EP0593627A1 Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
| 04/27/1994 | EP0593624A1 Improvements in or relating to contrast agents. |
| 04/27/1994 | EP0542829B1 Method for producing magnetic microparticles from metallocenes |
| 04/27/1994 | EP0462145B1 Covalent conjugates of lipid and oligonucleotide |
| 04/27/1994 | EP0445131B1 Liposomes |
| 04/26/1994 | US5305757 Gas filled liposomes and their use as ultrasonic contrast agents |
| 04/21/1994 | DE4235381A1 Appts. for prodn. of dispersions for cosmetic, pharmaceutical use etc. - uses high pressure extrusion through membrane filters |
| 04/20/1994 | EP0592474A1 Novel compositions for magnetic resonance imaging |
| 04/19/1994 | US5304325 Emulsions of fluorochemical, water, surfactant; synthetic blood |
| 04/14/1994 | WO1994008240A1 Drug composition to prevent desensitization of cellular receptors |
| 04/14/1994 | WO1994007922A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | WO1994007894A1 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
| 04/14/1994 | WO1994007540A1 X-ray contrast medium for examining large and small intestines |
| 04/14/1994 | WO1994007539A1 Microparticle preparations made from biodegradable copolymers |
| 04/14/1994 | WO1994007511A1 Antibodies detecting stromelysin cleavage products |
| 04/14/1994 | WO1994007417A1 Method of ultrasonic imaging of body cavities |
| 04/14/1994 | CA2145757A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 04/14/1994 | CA2144843A1 Antibodies detecting stromelysin cleavage products |
| 04/13/1994 | EP0592306A2 19F-MRI Contrast medium |
| 04/13/1994 | EP0591544A1 Reagent for nuclear magnetic resonance |
| 04/13/1994 | EP0591374A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 04/13/1994 | EP0591355A1 Porphycene compounds for photodynamic therapy |
| 04/13/1994 | EP0591290A1 Fluorophore assisted carbohydrate electrophoresis diagnosis |
| 04/12/1994 | US5302384 Administering to treat inflammation |
| 04/12/1994 | US5302372 Sonicating aqueous albumin-glucose solution with glycerine; forms gas-in-liquid microbubbles; injecting into patient |
| 04/12/1994 | US5302369 Microspheres for radiation therapy |
| 04/12/1994 | US5301688 Method for localization and therapy of occult bladder cancer |
| 04/12/1994 | US5301664 Methods and apparatus for drug delivery using supercritical solutions |
| 04/12/1994 | CA1328463C 9-anthrylalkyl compounds, their preparation and their use |
| 04/07/1994 | CA2107642A1 19f-mri contrast medium |
| 04/06/1994 | EP0590766A2 Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
| 04/06/1994 | EP0590309A2 Bone-related sulfatase-like protein and process for its production |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/05/1994 | US5300424 Composition for preservation of diagnostic test reagents |
| 04/05/1994 | US5300278 Binding antibodies |
| 03/31/1994 | WO1994007142A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 03/31/1994 | WO1994006805A1 Boron-gadolinium compounds and method of conducting imaging and/or neutron capture therapy with same |
| 03/31/1994 | WO1994006477A1 Improvements in or relating to contrast agents |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006291A1 Solid phase and combinatorial synthesis of compounds on a solid support |
| 03/31/1994 | WO1994006282A1 Transgenic animal models for neurodegenerative disease |
| 03/31/1994 | DE4232925A1 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung 3-, 8-substituted Deuteroporphyrinderivate, pharmaceutical compositions containing them and processes for their preparation |
| 03/31/1994 | DE4232755A1 Mikropartikelpräparationen aus biologisch abbaubaren Mischpolymeren Microparticle preparations made from biodegradable copolymers |
| 03/31/1994 | CA2144749A1 Improvements in or relating to contrast agents |
| 03/30/1994 | EP0589556A2 Carbohydrate-based anti-inflammatory agents |
| 03/30/1994 | EP0588994A1 FLUORESCENCE DIAGNOSTICS OF CANCER USING $g(d)-AMINO LEVULINIC ACID |
| 03/30/1994 | EP0588869A1 X-ray contrast agent |
| 03/30/1994 | CN1084524A Chemical compounds |
| 03/30/1994 | CN1084514A Polyazamacrocyclic compounds for complexation of metal ions |
| 03/30/1994 | CN1084410A Improvements in or relating to contrast agents |
| 03/30/1994 | CN1084391A Surface modified anticancer nanoparticles |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298262 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 03/29/1994 | US5297562 Method for detecting and treating Alzheimer's disease |
| 03/29/1994 | CA1328069C Perfluoro-crown ethers in fluorine magnetic resonance imaging |
| 03/23/1994 | EP0588754A1 Application of peptide/cell receptor kinetics utilizing radiolabelled somatostatin congeners in the IN SITU, IN VIVO detection and differentiation of neoplastic tissue |
| 03/23/1994 | EP0587770A1 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |